Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$329K Sell
6,296
-455
-7% -$23.7K ﹤0.01% 1793
2026
Q1
$313K Buy
6,751
+714
+12% +$37.6K ﹤0.01% 1729
2025
Q4
$317K Sell
6,037
-101
-2% -$5.12K ﹤0.01% 1714
2025
Q3
$334K Buy
+6,138
New +$329K ﹤0.01% 1668
2019
Q2
– Sell
-614
Closed -$32K – 1088
2019
Q1
$32K Buy
+614
New +$38.3K ﹤0.01% 913
2018
Q2
– Sell
-1,677
Closed -$111K – 1011
2018
Q1
$111K Buy
1,677
+870
+108% +$72.9K 0.01% 863
2017
Q4
$77K Buy
+807
New +$78.9K ﹤0.01% 811

Other funds holding VEON

Atria Investments's VEON Position: Q2 2026 in Review

Atria Investments reduced its VEON (VEON) stake by 6.7% in Q2 2026, selling an estimated $23.7K and leaving 6,296 shares worth $329K. The position accounts for ﹤0.01% of the portfolio, ranked #1793.

Atria Investments first reported a position in VEON in Q4 2017 and has held it in 7 quarters since. The position peaked at $334K in Q3 2025. 112 funds tracked by Wall St. Rank hold VEON as of Q2 2026.

  • Atria Investments held 6,296 shares of VEON worth $329K as of Q2 2026.
  • Atria Investments sold 455 VEON shares in Q2 2026, an estimated $23.7K.
  • VEON made up ﹤0.01% of Atria Investments's portfolio in Q2 2026, its #1793 holding.
  • Atria Investments first reported a position in VEON in Q4 2017 and has held it in 7 quarters since.
  • Atria Investments's VEON position peaked at $334K in Q3 2025.
  • 112 funds tracked by Wall St. Rank held VEON as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.